학술논문

P1027: UPDATED DURABILITY OF RESPONSE AND SAFETY IN MANIFEST ARM 3: PELABRESIB (CPI-0610) COMBINED WITH RUXOLITINIB FOR JAK INHIBITOR TREATMENT-NAÏVE PATIENTS WITH MYELOFIBROSIS
Document Type
article
Source
HemaSphere, Vol 7, p e26914cb (2023)
Subject
Diseases of the blood and blood-forming organs
RC633-647.5
Language
English
ISSN
2572-9241
82025649